J&J’s Multiple Myeloma Launches Pick Up Momentum

 
• By Jessica Merrill

Johnson & Johnson delivered solid third quarter sales and earnings, which led the company to raise 2023 financial guidance.

taking off
J&J said new launches are picking up momentum • Source: Shutterstock

More from Earnings

More from Business